Product Offerings
Product Categories:
Drug Discovery, Gene Editing, Clinical Research
Products:
Gene-Modified Animal Models, Antibody Production Services, Preclinical and Clinical Trials Support, CRISPR/Cas9 Technology
TRANS GENIC INC. is a biotechnology company founded in 1998, specializing in drug discovery support through the use of gene-modified animal models and biotechnology services. The company provides contract research services for preclinical and clinical trials, including gene-editing technology and antibody production. Additionally, TRANS GENIC engages in investment and consulting services, focusing on business succession, mergers, and corporate restructuring. The company aims to contribute to medical research and drug development globally.